Hematological Disorder in Patients With Angiodysplasia

StatusUnknown
PhaseNot specified
Started

Record status This record was last updated May 2, 2024 (before its estimated September 1, 2026 completion). Its status may not reflect the trial's current state.

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Apr 2024); last known: Not Yet Recruiting
  2. Start date: Jan 1, 2024 to Jun 1, 2024v7
  3. Start date: Nov 1, 2023 to Jan 1, 2024v6
  4. Re-verified, no change to tracked fieldsv5
  5. Start date: Oct 1, 2023 to Nov 1, 2023v4
Show 2 earlier versionsHide 2 earlier versions
  1. Start date: Sep 20, 2023 to Oct 1, 2023v3
  2. Eligibility criteria expanded, about 13 wordsv2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Assiut University
1,667 trials monitored
See 15 trials at risk
The study aim will be to assess the association between GIT angiodysplasia with any hematological disorders such as any specific coagulation disorders or anemia.
Trial Details
NCT Number NCT06050798
Lead Sponsor Assiut University
Conditions
(from sponsor)		 Angiodysplasia, Hematological Disease
Related terms Angiodysplasia, Hematologic Diseases
Enrollment 55 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov